Evaluating pharmacists' views, knowledge, and perception regarding generic medicines in New Zealand

Research in Social and Administrative Pharmacy

Volumn 7, Issue 3, 2011, Pages 294-305

  Babar, Zaheer Ud Din ^a   Grover, Piyush ^a   Stewart, Joanna ^b   Hogg, Michele ^a   Short, Leanne ^a   Seo, Hee Gyung ^a   Rew, Anne ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b THE UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

GENERIC DRUG;

ADULT; ARTICLE; ATTITUDE TO HEALTH; CROSS-SECTIONAL STUDY; ECONOMICS; FEMALE; HEALTH PERSONNEL ATTITUDE; HUMAN; LEGAL ASPECT; MALE; NEW ZEALAND; PERCEPTION; PHARMACIST; PHARMACOKINETICS; PHARMACY; PRESCRIPTION; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE;

ADULT; ATTITUDE OF HEALTH PERSONNEL; COMMUNITY PHARMACY SERVICES; CROSS-SECTIONAL STUDIES; DRUG PRESCRIPTIONS; DRUGS, GENERIC; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; NEW ZEALAND; PERCEPTION; PHARMACIES; PHARMACISTS; QUESTIONNAIRES; THERAPEUTIC EQUIVALENCY;

EID: 80052270309     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2010.06.004     Document Type: Article

References (57)

1. Associate Minister of Health, Minister of Health Medicines New Zealand: Contributing to Good Health Outcomes for All New Zealanders 2007, Ministry of Health, Wellington, [Internet Site]. [cited 2009 Aug 25]. Available at:. http://www.moh.govt.nz/moh.nsf/pagesmh/7236/%24File/medicines-nz.pdf.
2. Glover J., Hetzel D., Tennant S. Australia and New Zealand, Health Systems of International Encyclopedia of Public Health 2008, Academic Press, Oxford, 255-267.
3. Pharmaceutical Management Agency Information Sheets-Introduction to PHARMAC 2009 Jul 27, PHARMAC, Wellington, [Internet Site]. [cited 2009 Aug 25]. Available at:. http://pharmac.govt.nz/2008/12/16/01_PHARM_Infsheet_INTRO.pdf.
4. Williams G., Poynton M. PHARMAC Lecture-Professional Pharmacy Studies May 5, 2009, [Pharmacy 409], The University of Auckland, Auckland, New Zealand.
5. Morgan S., Boothe K. Prescription drug subsidies in Australia and New Zealand. Aust Prescr 2010, 33:2-4.
6. Morgan S., Henley G., McMahon M., Barer M. Influencing drug prices through formulary-based policies: lessons from New Zealand. Healthc Policy 2007, 3:1-20.
7. McCormack P., Quigley J., Hansen P. Review of Access to High-Cost, Highly-Specialised Medicines in New Zealand. Report Presented to Minister of Health Available at:, Accessed 28.05.10. http://www.beehive.govt.nz/sites/all/files/Review%20of%20Access%20to%20High%20Cost%20Highly%20Specialised%20Medicines%2031%20April%202010.pdf.
8. Ryall T. Health Minister confirms new medicines spending, 30th July 2009 Available at:, Accessed 13.06.10. http://www.beehive.govt.nz/release/health%2Bminister%2Bconfirms%2Bnew%2Bmedicines%2Bspending.
9. PHARMAC Pharmaceutical Management Agency Annual Review, New Zealand Government Available at:, Accessed 15.09.09. http://www.pharmac.govt.nz/2007/11/21/ARev071.pdf.
10. Kanavos P. Do generics offer significant savings to the UK National Health Service?. Curr Med Res Opin 2007, 23:105-116.
11. King D.R., Kanavos P. Encouraging the use of generic medicines: implications for transition economies. Croat Med J 2002, 43:462-469.
12. Generic medicines, basic notions: European Generic Medicines Association Available at:, Accessed 15.06.10. http://www.egagenerics.com/gen-basics.htm.
13. IMS IMS health data 2003 Available at:. http://www.imshealth.com.
14. Generic Prescribing Association of British Pharmaceutical Industry BSC/5/99/3k. Available at:, Accessed 16.06.10. http://www.kidney.org.uk/main/switch_meds/generic.pdf.
15. Lofgran H. Generic medicines in Australia: business dynamics and recent policy reform. South Med Rev 2009, 2:24-28. Available at:, Accessed 17.05.10. http://apps.who.int/medicinedocs/documents/s16383e/s16383e.pdf.
16. Matching US Generic Drug Use Would Save Canada $1.6-Billion, Toronto, April 6, 2010 Available at:, Accessed 18.05.10. http://www.canadiangenerics.ca/en/news/apr_06_10.asp.
17. Medsafe New Zealand Regulatory Guidelines for Medicines 2009, Vol. 1. Medsafe, Wellington, [cited 2009 Jul 8]. Available at:, Accessed 24.06.10. http://medsafe.govt.nz/regulatory/Guideline/Full%20-%20NZ%20Regulatory%20Guidelines%20for%20Medicines.pdf, 6.3 ed.
18. Borgheini G. The bioequivalence and therapeutic efficacy of generic versus brand-name psychoactive drugs. Clin Ther 2003, 25:1578-1592.
19. Cumming J., Mayes N., Daube J. How New Zealand has contained expenditures on drugs. BMJ 2010, 340:1224-1227.
20. Upfront: Brand Change Changing to a generic drug. BPac NZ [cited 1 May 2008]. Available at:, Accessed 15.05.10. http://www.bpac.org.nz/magazine/2007/june/upfront.asp.
21. Kalisch L., Roughead E., Gilbert A. Pharmaceutical brand substitution in Australia-are there multiple switches per prescription?. Aust N Z J Public Health 2007, 31:348-352.
22. Minutes of the PHARMAC Consumer Advisory Committee (CAC) Meeting, Friday 13 July 2007 Available at:, Accessed 13.02.10. http://www.pharmac.govt.nz/pdf/021007a.pdf.
23. Generic medicines: dealing with multiple brands. National Prescribing Service Newsletter. Australia Available at:, Accessed 16.06.10. http://www.nps.org.au/health_professionals/publications/nps_news/current/generic_medicines_dealing_with_multiple_brands.
24. Babar Z.U., Stewart J., Reddy S., et al. An evaluation of consumers' knowledge, perceptions and attitudes regarding generic medicines in Auckland [Online first]. Available at:, Accessed 28/6/2010. http://www.springerlink.com/content/2n22020r2x366782/?p=ed9bd33d6e5347b49bc417ad89486317%26pi=1.
25. Why you should prescribe generically. Best Pract Gen 2008, 14:24-27. Available at:, Accessed 26.06.10. http://www.bpac.org.nz/magazine/2008/june/generic.asp.
26. Pharmaceutical Management Agency Information Sheets-The Truth About Generic Medicines [Internet Site]. [cited 2009 August 25]. Available at:, Accessed 27.07.09. http://pharmac.govt.nz/2008/12/16/07_PHARM_Infosheets_GENERIC_MEDS.pdf.
27. Mott D., Cline R. Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution. Med Care 2002, 40(8):662-674.
28. Medsafe, Minister of Health Eltroxin-Medsafe Summary Review of Eltroxin (Media Conference Information) 2008 Sep 11, Medsafe, Wellington, [Internet Site]. [cited 2009 May 23]. Available at:, Accessed 25.06.10. http://www.medsafe.govt.nz/hot/MediaContents.asp.
29. Ford N., t'Hoen E. Generic medicines are not substandard medicines. Lancet 2002, 359:1351-1352.
30. Kjoenniksen I., Lindbaek M., Granas A. Patients' attitudes towards and experiences of generic drug substitution in Norway. Pharm World Sci 2006, 28:284-289.
31. Mason J., Bearden W. Generic drugs: consumer, pharmacist and physician perceptions of the issues. J Consum Aff 1980, 14:193-206.
32. Bearden W., Mason J. Physician and pharmacist perceptions of generic drugs. Ind Market Manag 1979, 8(1):63-68.
33. Medsafe Regulatory Issues-No Immediate Changes to Generics [Internet Site]. [cited 2009 May 23]. Available at:, Accessed 15.05.10. http://medsafe.govt.nz/profs/RIss/gensubleg.asp.
34. Maling T. Finding a better balance between pharmaceutical supply and demand-a medicinal issue. N Z Fam Phys 2002, 29:3.
35. Perkins E, Dovey S, Tilyard M, Boyle K, & Penrose A. A 30 change management strategy to modify ACE-inhibitor prescribing. RNZCGP Research Unit; 1999.
36. Babar Z., Awaisu A. Evaluating community pharmacists' perceptions and practices on generic medicines: a pilot study from Peninsular Malaysia. J Generic Med 2008, 5:315-330.
37. Hassali A., Stewart K. Quality use of generic medicines. Aust Prescr 2004, 27:80-81. Available at:, Accessed 26.06.10. http://www.australianprescriber.com/upload/pdf/articles/488.pdf.
38. SSRI antidepressants and brand changing. Best Pract J March 2007, 27. Special edition. Available at:, Accessed 20.06.10. http://www.bpac.org.nz/magazine/2007/march/changing.asp#ssri.
39. Al-Gedadi N.A., Hassali M.A., Shafie A.A. A pilot survey on perceptions and knowledge of generic medicines among consumers in Penang, Malaysia. Pharm Pract 2008, 6:93-97.
40. Request for proposal (RFP) supply of market services research (medication brand changes). Pharm Manag Agency N Z Jan 2008, 25th.
41. Smith F.J. Research Methods in Pharmacy Practice 2002, Pharmaceutical Press, 1-286.
42. Pharmacy Guild of New Zealand About the Pharmacy Guild-Facts at a Glance 2006, Pharmacy Guild of New Zealand, Wellington, [Internet Site]. Available at:, Accessed 26.06.10. http://www.pgnz.org.nz/about-us/.
43. Generics Survey. Pharmacy Today 2009, Jul, CMPMedica (NZ) Ltd, Auckland, 5. N. Sinclair (Ed.).
44. Scahill S., Harrison J., Sheridan J. The ABC of New Zealand's Ten Year Vision for pharmacists: awareness, barriers and consultation. Int J Pharm Pract 2009, 17:135-142.
45. Pharmacy Council of New Zealand Workforce Demographics as at 30th June 2009 Available at:, Accessed 20.06.10. http://www.pharmacycouncil.org.nz/cms_show_download.php%3Fid=125.
46. Allenet B., Barry H. Opinion and behaviour of pharmacists towards the substitution of branded drugs by generic drugs: survey of 1,000 French community pharmacists. Pharm World Sci 2003, 25:197-202.
47. Tatley M. Monitoring of generic medicines and brand changes. BPJ Spec Ed Generics 2009, 18-20. Available at:, Accessed 26.05.10. http://www.bpac.org.nz/magazine/2009/generics/generics.asp?article=6.
48. New Zealand Pharmacovigilance Centre-CARM CARM Background Information 2009 Sep, CARM, Dunedin, [Internet Site]. [cited 2009 Sep 15]. Available at:, Accessed 19.06.10. http://carm.otago.ac.nz/index.asp%3Flink=carm.
49. Lamy P.P. Generic equivalents: issues and concerns. J Clin Pharmacol 1986, 26:309-316.
50. Al-Gedadi N., Azmi Hassali M. Pharmacists' views on generic medicines: a review of the literature. J Generic Med 2008, 5:209-218.
51. Barrett L.L., AARP Knowledge Management Pharmacists' Attitudes and Practices Regarding Generic Drugs 2005 Sep, AARP, Washington, [Serial on the Internet]. [cited 2009 Aug 18]. Available at:, Accessed 27.06.10. http://www.aarp.org/research.
52. Kirking D.M., Gaither C.A., Ascione F.J., Welage L.S. Physicians individual and organizational views on generic medications. J Am Pharm Assoc 2001, 41:718-722.
53. Meredith P.A. Generic drugs-therapeutic equivalence. Drug Saf 1996, 15:233-242.
54. Medsafe Interchangeable Status (IMM) [Internet Site]. [cited 2009 Sep 23]. Available at:, Accessed 07.07.06. http://medsafe.govt.nz/profs/imm.asp.
55. Purvis L., AARP Public Policy Institute Strategies to Increase Generic Drug Utilization and Associated Savings 2008 Dec, AARP, Washington, [Serial on the Internet]. [cited 2009 Aug 18]. Available at:, Accessed 15.06.10. http://assets.aarp.org/rgcenter/health/i16_generics.pdf.
56. Banahan B.F., Kolaassa E.M. Generic Substitution and Narrow Therapeutic Index Drugs-A National Survey of Retail and Hospital Pharmacies 1994, University of Mississippi, Oxford, Mississippi.
57. Pharmacist claiming, Media Release Available at:, Accessed 22.06.10. http://www.moh.govt.nz/moh.nsf/pagesmh/5284%3FOpen.